Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics

MH Elbahoty, B Papineni, RS Samant - Clinical & Experimental Metastasis, 2024 - Springer
Multiple myeloma (MM) is a clinical disorder characterized by aberrant plasma cell growth in
the bone marrow microenvironment. Globally, the prevalence of MM has been steadily …

PCMMD: A Novel Dataset of Plasma Cells to Support the Diagnosis of Multiple Myeloma

C LB Andrade, MV Ferreira, B M. Alencar, JL SB Filho… - Scientific Data, 2025 - nature.com
Multiple Myeloma (MM) is a cytogenetically heterogeneous clonal plasma cell proliferative
disease whose diagnosis is supported by analyses on histological slides of bone marrow …

B4GALT3 as a Key Glycosyltransferase Gene in Multiple Myeloma Progression: Insights from Bioinformatics, Machine Learning, and Experimental Validation

A Yang, M Ke, L Feng, Y Yang, J Chen, Z Zeng - 2025 - researchsquare.com
Background: Glycosylation abnormalities are critical in the progression of various cancers.
However, their role in the onset and prognosis of multiple myeloma (MM) remains …

PCMMD: a Novel Dataset of Plasma Cells to Support the Diagnosis of Multiple Myeloma

MM dos Santos, MICS e Silva, IM Rosa… - search.proquest.com
Multiple Myeloma (MM) is a cytogenetically heterogeneous clonal plasma cell proliferative
disease whose diagnosis is supported by analyses on histological slides of bone marrow …

[CITAAT][C] Artificial intelligence in hematology: A critical perspective

K Singh, A Singh - J Clin Exp Hematol, 2024